Inhibition of insulin release by enterostatin

International Journal of Obesity

Volumn 22, Issue 8, 1998, Pages 800-805

  Ookuma, M ^a   York, D A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

cAMP; Glybenclamide; Potassium channel; U50,488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 8 BROMO CYCLIC AMP; CALCIUM ION; CYCLIC AMP; ENTEROSTATIN; GLIBENCLAMIDE; INSULIN; PHORBOL 12 ACETATE 13 MYRISTATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031822434     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800663     Document Type: Article

References (38)

1. Sorhede M, Mulder H, Mei J, Sundler F, Erlanson-Albertsson C. Procolipase is produced in the rat stomach - a novel source of enterostatin. Biochim Biophys Acta 1996; 1301: 207-212.
2. Okada S, York DA, Bray GA. Procolipase mRNA: tissue localization and effects of diet and adrenalectomy. Biochem J 1993; 292: 787-789.
3. Erlanson-Albertsson C. Pancreatic colipase. Structural and physiological aspects. Biochem Biophys Acta 1992; 1125: 1-7.
4. Erlanson-Albertsson C, York DA. Enterostatin - a peptide regulating fat intake. Obes Res 1997; 5: 360-372.
5. Erlanson-Albertsson C, Larsson A. A possible physiological function of procolipase activation peptide in appetite regulation. Biochimie 1988; 60: 1245-1250.
6. Erlanson-Albertsson C, Larsson A. The activation peptide of pancreatic procolipase decreases food intake in rats. Regul Peptides 1988; 22: 325-331.
7. Erlanson-Albertsson C, Mei J, Okada S, York DA, Bray GA. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav 1991; 49: 1191-1194.
8. Okada S, York DA, Bray GA, Erlanson-Albertsson C. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase selectivity reduces fat intake. Physiol Behav 1991; 49: 1185-1189.
9. Shargill NS, Tsujii S, Bray GA, Erlanson-Albertsson C. Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Res 1991; 544: 137-140.
10. Tian, Q, Nagase M, York DA, Bray GA. Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin. Obesity Res 1994; 2: 527-534.
11. York DA, Lin L. Enterostatin and fat intake: current insights into possible mechanisms. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Medelson R (eds). Progress in Obesity Research 7: 7th International Congress on Obesity. John Libbey & Company Ltd: London, 1996, pp 495-501.
12. Barton C, Lin L, York DA, Bray GA. Differential effects of enterostatin, galanin and opioids on high-fat diet consumption. Brain Res 1995; 702: 55-60.
13. Ookuma K, Barton C, York DA, Bray GA. Effect of enterostatin and kappa-opioids on macronutrient selection and consumption. Peptides 1997; 18: 785-791.
14. Lin L, York DA. Metergoline blocks the feeding response to enterostatin (Abstract). Appetite 1994; 23: 313.
15. Nagase H, Bray GA, York DA. Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res 1996; 709: 44-50.
16. Erlanson-Albertsson C, Hering B. Bretzel RG, Federlin K. Enterostatin inhibits insulin secretion from isolated perifused rat islets. Acta Diabetol 1994; 31: 160-163.
17. Lin L, Chen J, York DA. Chronic icv enterostatin preferentially reduced fat intake and lowered body weight. Peptides 1997; 18: 657-661.
18. Mei J, Chen Y, Erlanson-Albertsson C. Enterostatin - its ability to inhibit insulin secretion and to decrease high-fat food intake. Int J Obes 1993; 17: 701-704.
19. Okada S, Lin L, York DA, Bray GA. Chronic effects of intracerebroventricular enterostatin in Osborne-Mendel rats fed a high fat diet. Physiol Behav 1993; 54: 325-329.
20. Mei J, Erlanson-Albertsson C. Plasma insulin in response to enterostatin and effect of adrenalectomy in rats. Obes Res 1996; 4: 513-519.
21. Silvestre RA, Rodriguez-Gallardo J, Marco J. Effects of enterostatin on insulin, glucagon, and somatostatin secretion in perfused rat pancreas. Diabetes 1996; 45: 1157-1160.
22. Gotoh M, Mayumi H, Himeno K, Tokuda N, Nomoto K. An Improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437-438.
23. Okada T, Ono J, Takaki R, Todo S. Simple method for collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Japon 1979; 26: 495-499.
24. Lin L, Okada S, York DA, Bray GA. Structural requirements for the biological activity of enterostatin. Peptides 1994; 15: 849-854.
25. Boyd AE. Sulphonylurea receptors, ion channels and fruit flies. Diabetes 1988; 37: 847-850.
26. Easom RA, Hughes JH, Landt M, Wolf BA, Turk J, McDaniel ML. Comparison of effect of phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem J 1989; 264: 27-33.
27. 2+ concentration. J Biol Chem 1989; 264: 2455-2462.
28. Zawalich W, Brown C, Ramussen H. Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun 1983; 117: 448-455.
29. McCarty MF. Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion - the 'PKC syndrome.'. Med Hypotheses 1996; 46: 191-221.
30. Ämmälä C, Aschcroft FM. Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 1993; 363: 356-358.
31. Lala A, Bouloux P, Tamburrano G, Gale E. Opioid peptides and glucose metabolism. J Endocrinol Invest 1987; 10: 95-104.
32. Ehrereich H, Goebel F-D. The role of opioids in the endocrine function of pancreas. Diabetes Res 1986; 3: 59-66.
33. Van Loon GR, Appel NM. Beta-endorphin-induced hyperglycemias mediated by increase central sympathetic outflow to adrenal medulla. Brain Res 1981; 204: 236-242.
34. Zhang M, Zheng M, Schleicher RL. Autoradiographic localization of beta-endorphin binding in the pancreas. Mol Cell Neurosci 1994; 5: 684-690.
35. Green IC, Perrin D, Penman E, Yassen A, Ray K, Howell SL. Effects of dynorphin on insulin and somatostatin secretion, calcium uptake and cAMP levels in isolated rat islets of Langerhans. Diabetes 1982; 32: 685-690.
36. Morley JE, Levine AS, Yim GK, Lowy MT. Opioid modulation of appetite. Neurosci Behav Rev 1988; 7: 281-305.
37. Laychock SG. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets. Mol Cell Endocrinol 1995; 113: 19-28.
38. Schuit FC. Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Hormone Res 1996; 46: 99-106.